{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:14:11Z","timestamp":1789600451374,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DFG","award":["SFB1181"],"award-info":[{"award-number":["SFB1181"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00281-019-00770-3","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T16:12:20Z","timestamp":1573229540000},"page":"665-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Resolution of allergic asthma"],"prefix":"10.1007","volume":"41","author":[{"given":"Susetta","family":"Finotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"issue":"1","key":"770_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00063198-200001000-00002","volume":"6","author":"TV Hartert","year":"2000","unstructured":"Hartert TV, Peebles RS Jr (2000) Epidemiology of asthma: the year in review. Curr Opin Pulm Med 6(1):4\u20139","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"770_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/pai.12881","volume":"29","author":"P Xepapadaki","year":"2018","unstructured":"Xepapadaki P, Bachert C, Finotto S, Jartti T, Konstantinou GN, Kiefer A, Kowalski M, Lewandowska-Polak A, Lukkarinen H, Roumpedaki E, Sobanska A, Sintobin I, Vuorinen T, Zhang N, Zimmermann T, Papadopoulos NG (2018) Contribution of repeated infections in asthma persistence from preschool to school age: design and characteristics of the PreDicta cohort. Pediatr Allergy Immunol 29(4):383\u2013393","journal-title":"Pediatr Allergy Immunol"},{"key":"770_CR3","doi-asserted-by":"crossref","unstructured":"Megremis S, Niespodziana K, Cabauatan C, Xepapadaki P, Kowalski ML, Jartti T, Bachert C, Finotto S, West P, Stamataki S, Lewandowska-Polak A, Lukkarinen H, Zhang N, Zimmermann T, Stolz F, Neubauer A, Akdis M, Andreakos E, Valenta R, Papadopoulos NG (2018) Rhinovirus species-specific antibodies differentially reflect clinical outcomes in health and asthma. Am J Respir Crit Care Med","DOI":"10.1164\/rccm.201803-0575OC"},{"issue":"7","key":"770_CR4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tim.2015.03.005","volume":"23","author":"CS Earl","year":"2015","unstructured":"Earl CS, An SQ, Ryan RP (2015) The changing face of asthma and its relation with microbes. Trends Microbiol 23(7):408\u2013418","journal-title":"Trends Microbiol"},{"issue":"25","key":"770_CR5","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1056\/NEJMct055184","volume":"354","author":"RC Strunk","year":"2006","unstructured":"Strunk RC, Bloomberg GR (2006) Omalizumab for asthma. N Engl J Med 354(25):2689\u20132695","journal-title":"N Engl J Med"},{"issue":"14","key":"770_CR6","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1074\/jbc.RA118.005418","volume":"294","author":"Q Chen","year":"2019","unstructured":"Chen Q, Guo X, Deng N, Liu L, Chen S, Wang A, Li R, Huang Y, Ding X, Yu H, Hu S, Nie H (2019) alpha-galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma. J Biol Chem 294(14):5438\u20135455","journal-title":"J Biol Chem"},{"issue":"2","key":"770_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cpt.1371","volume":"106","author":"YL Chia","year":"2019","unstructured":"Chia YL, Yan L, Yu B, Wang B, Barker P, Goldman M, Roskos L (2019) Relationship Between benralizumab exposure and efficacy for patients with severe eosinophilic asthma. Clin Pharmacol Ther 106(2):383\u2013390","journal-title":"Clin Pharmacol Ther"},{"key":"770_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fped.2019.00246","volume":"7","author":"SC Dharmage","year":"2019","unstructured":"Dharmage SC, Perret JL, Custovic A (2019) Epidemiology of asthma in children and adults. Front Pediatr 7:246","journal-title":"Front Pediatr"},{"key":"770_CR9","doi-asserted-by":"crossref","unstructured":"Fishe JN, Palmer E, Finlay E, Smotherman C, Gautam S, Hendry P, Hendeles L (2019) A statewide study of the epidemiology of emergency medical services\u2019 management of pediatric asthma. Pediatr Emerg Care","DOI":"10.1097\/PEC.0000000000001743"},{"issue":"4","key":"770_CR10","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jaci.2018.06.052","volume":"143","author":"BW Morgan","year":"2019","unstructured":"Morgan BW, Grigsby MR, Siddharthan T, Chowdhury M, Rubinstein A, Gutierrez L, Irazola V, Miranda JJ, Bernabe-Ortiz A, Alam D, Wise RA, Checkley W (2019) Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries. J Allergy Clin Immunol 143(4):1598\u20131606","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"770_CR11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaci.2015.02.035","volume":"136","author":"JE Sordillo","year":"2015","unstructured":"Sordillo JE, Kelly R, Bunyavanich S, McGeachie M, Qiu W, Croteau-Chonka DC, Soto-Quiros M, Avila L, Celedon JC, Brehm JM, Weiss ST, Gold DR, Litonjua AA (2015) Genome-wide expression profiles identify potential targets for gene-environment interactions in asthma severity. J Allergy Clin Immunol 136(4):885\u201392 e2","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"770_CR12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2731","volume":"18","author":"ST Holgate","year":"2012","unstructured":"Holgate ST (2012) Innate and adaptive immune responses in asthma. Nat Med 18(5):673\u2013683","journal-title":"Nat Med"},{"issue":"4","key":"770_CR13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","volume":"50","author":"BN Lambrecht","year":"2019","unstructured":"Lambrecht BN, Hammad H, Fahy JV (2019) The cytokines of asthma. Immunity 50(4):975\u2013991","journal-title":"Immunity"},{"issue":"6","key":"770_CR14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/cea.13359","volume":"49","author":"K Alagha","year":"2019","unstructured":"Alagha K, Bourdin A, Vernisse C, Garulli C, Tummino C, Charriot J, Vachier I, Suehs C, Chanez P, Gras D (2019) Goblet cell hyperplasia as a feature of neutrophilic asthma. Clin Exp Allergy 49(6):781\u2013788","journal-title":"Clin Exp Allergy"},{"key":"770_CR15","doi-asserted-by":"crossref","unstructured":"Bullone M, Carriero V, Bertolini F, Folino A, Mannelli A, Di Stefano A, Gnemmi I, Torchio R, Ricciardolo FLM (2019) Elevated serum IgE, OCS-dependence and IL-17\/22 expression in highly neutrophilic asthma. Eur Respir J","DOI":"10.1183\/13993003.00068-2019"},{"key":"770_CR16","doi-asserted-by":"crossref","unstructured":"Kalchiem-Dekel O, Yao X, Levine SJ (2019) Meeting the challenge of identifying new treatments for type 2-low neutrophilic asthma. Chest","DOI":"10.1016\/j.chest.2019.08.2192"},{"issue":"2","key":"770_CR17","doi-asserted-by":"crossref","first-page":"1900547","DOI":"10.1183\/13993003.00547-2019","volume":"54","author":"Abilash Ravi","year":"2019","unstructured":"Ravi A, Chowdhury S, Dijkhuis A, Bonta PI, Sterk PJ, Lutter R (2019) Neutrophilic inflammation in asthma and defective epithelial translational control. Eur Respir J 54(2)","journal-title":"European Respiratory Journal"},{"issue":"11","key":"770_CR18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/milmed\/165.11.852","volume":"165","author":"KL Clark","year":"2000","unstructured":"Clark KL, Li Y, Krauss MR, Kelley PW (2000) The asthma accession standard: a survival analysis of military recruits, 1995 to 1997. Mil Med 165(11):852\u2013854","journal-title":"Mil Med"},{"key":"770_CR19","first-page":"1","volume":"18","author":"H Liu","year":"2019","unstructured":"Liu H, Tan J, Liu J, Feng H, Pan D (2019) Altered mast cell activity in response to rhinovirus infection provides novel insight into asthma. J Asthma 18:1\u20139","journal-title":"J Asthma"},{"issue":"6","key":"770_CR20","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/cea.13388","volume":"49","author":"M Salomonsson","year":"2019","unstructured":"Salomonsson M, Malinovschi A, Kalm-Stephens P, Dahlin JS, Janson C, Alving K, Hallgren J (2019) Circulating mast cell progenitors correlate with reduced lung function in allergic asthma. Clin Exp Allergy 49(6):874\u2013882","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"770_CR21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12016-018-8720-1","volume":"56","author":"DEA Komi","year":"2019","unstructured":"Komi DEA, Bjermer L (2019) Mast Cell-mediated orchestration of the immune responses in human allergic asthma: current insights. Clin Rev Allergy Immunol 56(2):234\u2013247","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"770_CR22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2018-211540","volume":"73","author":"HL Petsky","year":"2018","unstructured":"Petsky HL, Cates CJ, Kew KM, Chang AB (2018) Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Thorax 73(12):1110\u20131119","journal-title":"Thorax"},{"issue":"5","key":"770_CR23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s40273-017-0608-z","volume":"36","author":"K Cooper","year":"2018","unstructured":"Cooper K, Frampton G, Harris P, Rose M, Chorozoglou M, Pickett K (2018) Reslizumab for Treating asthma with elevated blood eosinophils inadequately controlled by inhaled corticosteroids: an evidence review group perspective of a NICE single technology appraisal. pharmacoeconomics 36(5):545\u2013553","journal-title":"pharmacoeconomics"},{"issue":"576","key":"770_CR24","doi-asserted-by":"crossref","first-page":"eaav2060","DOI":"10.1126\/scisignal.aav2060","volume":"12","author":"Soichiro Yoshikawa","year":"2019","unstructured":"Yoshikawa S, Oh-Hora M, Hashimoto R, Nagao T, Peters L, Egawa M, Ohta T, Miyake K, Adachi T, Kawano Y, Yamanishi Y, Karasuyama H (2019) Pivotal role of STIM2, but not STIM1, in IL-4 production by IL-3-stimulated murine basophils. Sci Signal 12(576)","journal-title":"Science Signaling"},{"issue":"1","key":"770_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0090-6980(86)90153-X","volume":"32","author":"M Cirino","year":"1986","unstructured":"Cirino M, Lagente V, Lefort J, Vargaftig BB (1986) A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. Prostaglandins 32(1):121\u2013126","journal-title":"Prostaglandins"},{"issue":"1","key":"770_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaip.2018.04.043","volume":"7","author":"TB Casale","year":"2019","unstructured":"Casale TB, Luskin AT, Busse W, Zeiger RS, Trzaskoma B, Yang M, Griffin NM, Chipps BE (2019) Omalizumab Effectiveness by biomarker status in patients with asthma: evidence from PROSPERO, a prospective real-world study. J Allergy Clin Immunol Pract 7(1):156\u2013164 e1","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"770_CR27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12931-018-0813-0","volume":"19","author":"A Matucci","year":"2018","unstructured":"Matucci A, Vultaggio A, Maggi E, Kasujee I (2018) Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir Res 19(1):113","journal-title":"Respir Res"},{"issue":"1","key":"770_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3341","volume":"13","author":"HF Rosenberg","year":"2013","unstructured":"Rosenberg HF, Dyer KD, Foster PS (2013) Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 13(1):9\u201322","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"770_CR29","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1172\/JCI85664","volume":"126","author":"C Mesnil","year":"2016","unstructured":"Mesnil C, Raulier S, Paulissen G, Xiao X, Birrell MA, Pirottin D, Janss T, Starkl P, Ramery E, Henket M, Schleich FN, Radermecker M, Thielemans K, Gillet L, Thiry M, Belvisi MG, Louis R, Desmet C, Marichal T, Bureau F (2016) Lung-resident eosinophils represent a distinct regulatory eosinophil subset. J Clin Invest 126(9):3279\u20133295","journal-title":"J Clin Invest"},{"issue":"1","key":"770_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1074-7613(00)80294-0","volume":"4","author":"M Kopf","year":"1996","unstructured":"Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI (1996) IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4(1):15\u201324","journal-title":"Immunity"},{"key":"770_CR31","doi-asserted-by":"crossref","unstructured":"Radermecker C, Sabatel C, Vanwinge C, Ruscitti C, Marechal P, Perin F, Schyns J, Rocks N, Toussaint M, Cataldo D, Johnston SL, Bureau F, Marichal T (2019) Locally instructed CXCR4(hi) neutrophils trigger environment-driven allergic asthma through the release of neutrophil extracellular traps. Nat Immunol","DOI":"10.1038\/s41590-019-0496-9"},{"key":"770_CR32","doi-asserted-by":"crossref","unstructured":"Ekstedt S, Stenberg H, Tufvesson E, Diamant Z, Bjermer L, Kumlien Georen S, Cardell LO (2019) The potential role of CD16(high) CD62L(dim) neutrophils in the allergic asthma. Allergy","DOI":"10.1111\/all.13861"},{"issue":"2","key":"770_CR33","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jaip.2018.11.013","volume":"7","author":"WW Busse","year":"2019","unstructured":"Busse WW (2019) What are those neutrophils doing in severe asthma anyway? J Allergy Clin Immunol Pract 7(2):526\u2013528","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"770_CR34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2018.08.024","volume":"7","author":"JR Grunwell","year":"2019","unstructured":"Grunwell JR, Stephenson ST, Tirouvanziam R, Brown LAS, Brown MR, Fitzpatrick AM (2019) Children with neutrophil-predominant severe asthma have proinflammatory neutrophils with enhanced survival and impaired clearance. J Allergy Clin Immunol Pract 7(2):516\u2013525 e6","journal-title":"J Allergy Clin Immunol Pract"},{"key":"770_CR35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coi.2018.05.006","volume":"54","author":"C Radermecker","year":"2018","unstructured":"Radermecker C, Louis R, Bureau F, Marichal T (2018) Role of neutrophils in allergic asthma. Curr Opin Immunol 54:28\u201334","journal-title":"Curr Opin Immunol"},{"key":"770_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2017.09.002","volume":"191","author":"A Saradna","year":"2018","unstructured":"Saradna A, Do DC, Kumar S, Fu QL, Gao P (2018) Macrophage polarization and allergic asthma. Transl Res 191:1\u201314","journal-title":"Transl Res"},{"issue":"9","key":"770_CR37","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/jcm8091451","volume":"8","author":"Fu-Tsai Chung","year":"2019","unstructured":"Chung FT, Huang HY, Lo CY, Huang YC, Lin CW, He CC, He JR, Sheng TF, Wang CH (2019) Increased ratio of matrix metalloproteinase-9 (MMP-9)\/Tissue inhibitor metalloproteinase-1 from alveolar macrophages in chronic asthma with a fast decline in FEV1 at 5-year follow-up. J Clin Med 8(9)","journal-title":"Journal of Clinical Medicine"},{"issue":"3","key":"770_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.anai.2019.05.019","volume":"123","author":"Y Tokunaga","year":"2019","unstructured":"Tokunaga Y, Imaoka H, Kaku Y, Kawayama T, Hoshino T (2019) The significance of CD163-expressing macrophages in asthma. Ann Allergy Asthma Immunol 123(3):263\u2013270","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"770_CR39","doi-asserted-by":"crossref","first-page":"L369","DOI":"10.1152\/ajplung.00456.2018","volume":"316","author":"LES de Groot","year":"2019","unstructured":"de Groot LES, van der Veen TA, Martinez FO, Hamann J, Lutter R, Melgert BN (2019) Oxidative stress and macrophages: driving forces behind exacerbations of asthma and chronic obstructive pulmonary disease? Am J Physiol Lung Cell Mol Physiol 316(2):L369\u2013L384","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"770_CR40","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1038\/srep05865","volume":"4","author":"C Ubel","year":"2014","unstructured":"Ubel C, Graser A, Koch S, Rieker RJ, Lehr HA, Muller M, Finotto S (2014) Role of Tyk-2 in Th9 and Th17 cells in allergic asthma. Sci Rep 4:5865","journal-title":"Sci Rep"},{"issue":"4","key":"770_CR41","first-page":"3210","volume":"19","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wang L (2019) Ovalbumin induces natural killer cells to secrete Th2 cytokines IL5 and IL13 in a mouse model of asthma. Mol Med Rep 19(4):3210\u20133216","journal-title":"Mol Med Rep"},{"issue":"7","key":"770_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11882-017-0714-1","volume":"17","author":"B Leomicronn","year":"2017","unstructured":"Leomicronn B (2017) T cells in allergic asthma: key players beyond the Th2 pathway. Curr Allergy Asthma Rep 17(7):43","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"770_CR43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12708","volume":"286","author":"L Krabbendam","year":"2018","unstructured":"Krabbendam L, Bal SM, Spits H, Golebski K (2018) New insights into the function, development, and plasticity of type 2 innate lymphoid cells. Immunol Rev 286(1):74\u201385","journal-title":"Immunol Rev"},{"issue":"2 Pt 1","key":"770_CR44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(99)70493-8","volume":"103","author":"Y Nakamura","year":"1999","unstructured":"Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, Zhang DH, Ray A, Hamid Q (1999) Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 103(2 Pt 1):215\u2013222","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"770_CR45","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.193.11.1247","volume":"193","author":"S Finotto","year":"2001","unstructured":"Finotto S, De Sanctis GT, Lehr HA, Herz U, Buerke M, Schipp M, Bartsch B, Atreya R, Schmitt E, Galle PR, Renz H, Neurath MF (2001) Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J Exp Med 193(11):1247\u20131260","journal-title":"J Exp Med"},{"issue":"21","key":"770_CR46","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1411776","volume":"372","author":"N Krug","year":"2015","unstructured":"Krug N, Hohlfeld JM, Kirsten AM, Kornmann O, Beeh KM, Kappeler D, Korn S, Ignatenko S, Timmer W, Rogon C, Zeitvogel J, Zhang N, Bille J, Homburg U, Turowska A, Bachert C, Werfel T, Buhl R, Renz J, Garn H, Renz H (2015) Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. N Engl J Med 372(21):1987\u20131995","journal-title":"N Engl J Med"},{"issue":"1","key":"770_CR47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jaci.2013.09.049","volume":"133","author":"C Ubel","year":"2014","unstructured":"Ubel C, Sopel N, Graser A, Hildner K, Reinhardt C, Zimmermann T, Rieker RJ, Maier A, Neurath MF, Murphy KM, Finotto S (2014) The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast cell-driven immune responses in the setting of allergic asthma. J Allergy Clin Immunol 133(1):198\u2013206 e1-9","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"770_CR48","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1172\/JCI69489","volume":"123","author":"R Jabeen","year":"2013","unstructured":"Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, Attenasio A, Walsh D, Olson MR, Kim MH, Tepper RS, Sun J, Kim CH, Taparowsky EJ, Zhou B, Kaplan MH (2013) Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest 123(11):4641\u20134653","journal-title":"J Clin Invest"},{"issue":"3","key":"770_CR49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.coi.2012.02.001","volume":"24","author":"R Jabeen","year":"2012","unstructured":"Jabeen R, Kaplan MH (2012) The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol 24(3):303\u2013307","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"770_CR50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/imr.12028","volume":"252","author":"MH Kaplan","year":"2013","unstructured":"Kaplan MH (2013) Th9 cells: differentiation and disease. Immunol Rev 252(1):104\u2013115","journal-title":"Immunol Rev"},{"issue":"9","key":"770_CR51","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1073\/pnas.1301138111","volume":"111","author":"W Liao","year":"2014","unstructured":"Liao W, Spolski R, Li P, Du N, West EE, Ren M, Mitra S, Leonard WJ (2014) Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc Natl Acad Sci U S A 111(9):3508\u20133513","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"770_CR52","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.immuni.2013.07.020","volume":"39","author":"P Licona-Limon","year":"2013","unstructured":"Licona-Limon P, Henao-Mejia J, Temann AU, Gagliani N, Licona-Limon I, Ishigame H, Hao L, Herbert DR, Flavell RA (2013) Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 39(4):744\u2013757","journal-title":"Immunity"},{"issue":"1","key":"770_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00281-016-0611-z","volume":"39","author":"MF Neurath","year":"2017","unstructured":"Neurath MF, Kaplan MH (2017) Th9 cells in immunity and immunopathological diseases. Semin Immunopathol 39(1):1\u20134","journal-title":"Semin Immunopathol"},{"issue":"5 Pt 2","key":"770_CR54","doi-asserted-by":"crossref","first-page":"S485","DOI":"10.1016\/S0091-6749(99)70165-X","volume":"103","author":"RC Levitt","year":"1999","unstructured":"Levitt RC, McLane MP, MacDonald D, Ferrante V, Weiss C, Zhou T, Holroyd KJ, Nicolaides NC (1999) IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol 103(5 Pt 2):S485\u2013S491","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12890-015-0119-7","volume":"15","author":"D Hoppenot","year":"2015","unstructured":"Hoppenot D, Malakauskas K, Lavinskiene S, Sakalauskas R (2015) p-STAT6, PU.1, and NF-kappaB are involved in allergen-induced late-phase airway inflammation in asthma patients. BMC Pulm Med 15:122","journal-title":"BMC Pulm Med"},{"issue":"1","key":"770_CR56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.medici.2015.01.001","volume":"51","author":"D Hoppenot","year":"2015","unstructured":"Hoppenot D, Malakauskas K, Lavinskiene S, Bajoriuniene I, Kalinauskaite V, Sakalauskas R (2015) Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients. Medicina 51(1):10\u201317","journal-title":"Medicina"},{"key":"770_CR57","doi-asserted-by":"crossref","unstructured":"Finotto S (2018) B lymphocyte-induced maturation protein 1 (Blimp-1), a negative regulator of TH9 development, orchestrates the resolution of airway inflammation in patients with allergic asthma. J Allergy Clin Immunol","DOI":"10.1016\/j.jaci.2018.07.039"},{"issue":"6","key":"770_CR58","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1067\/mai.2003.1485","volume":"111","author":"VJ Erpenbeck","year":"2003","unstructured":"Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A, Krug N (2003) Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 111(6):1319\u20131327","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"770_CR59","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.4049\/jimmunol.166.4.2768","volume":"166","author":"S Abdelilah","year":"2001","unstructured":"Abdelilah S, Latifa K, Esra N, Cameron L, Bouchaib L, Nicolaides N, Levitt R, Hamid Q (2001) Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J Immunol 166(4):2768\u20132774","journal-title":"J Immunol"},{"issue":"3","key":"770_CR60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s004080000018","volume":"178","author":"PR Bhathena","year":"2000","unstructured":"Bhathena PR, Comhair SA, Holroyd KJ, Erzurum SC (2000) Interleukin-9 receptor expression in asthmatic airways In vivo. Lung 178(3):149\u2013160","journal-title":"Lung"},{"issue":"3","key":"770_CR61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.2105079","volume":"166","author":"G Cheng","year":"2002","unstructured":"Cheng G, Arima M, Honda K, Hirata H, Eda F, Yoshida N, Fukushima F, Ishii Y, Fukuda T (2002) Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 166(3):409\u2013416","journal-title":"Am J Respir Crit Care Med"},{"issue":"1 Pt 1","key":"770_CR62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0091-6749(00)90185-4","volume":"105","author":"A Shimbara","year":"2000","unstructured":"Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, Nicolaides NC, Holroyd KJ, Tsicopoulos A, Lafitte JJ, Wallaert B, Hamid QA (2000) IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 105(1 Pt 1):108\u2013115","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"770_CR63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1067\/mai.2002.121555","volume":"109","author":"M Toda","year":"2002","unstructured":"Toda M, Tulic MK, Levitt RC, Hamid Q (2002) A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol 109(2):246\u2013250","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1465-9921-14-93","volume":"14","author":"CK Oh","year":"2013","unstructured":"Oh CK, Leigh R, McLaurin KK, Kim K, Hultquist M, Molfino NA (2013) A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma. Respir Res 14:93","journal-title":"Respir Res"},{"issue":"2","key":"770_CR65","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaci.2016.03.049","volume":"139","author":"FJ Rubner","year":"2017","unstructured":"Rubner FJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, Gern JE, Lemanske RF Jr (2017) Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol 139(2):501\u2013507","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"770_CR66","doi-asserted-by":"crossref","first-page":"1700265","DOI":"10.1183\/13993003.00265-2017","volume":"49","author":"Annika Bergauer","year":"2017","unstructured":"Bergauer A, Sopel N, Kross B, Vuorinen T, Xepapadaki P, Weiss ST, Blau A, Sharma H, Kraus C, Springel R, Rauh M, Mittler S, Graser A, Zimmermann T, Melichar VO, Kiefer A, Kowalski ML, Sobanska A, Jartti T, Lukkarinen H, Papadopoulos NG, Finotto S (2017) Rhinovirus species\/genotypes and interferon-lambda: subtypes, receptor and polymorphisms - missing pieces of the puzzle of childhood asthma? Eur Respir J 49(3)","journal-title":"European Respiratory Journal"},{"key":"770_CR67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ebiom.2017.03.033","volume":"19","author":"TT Hansel","year":"2017","unstructured":"Hansel TT, Tunstall T, Trujillo-Torralbo MB, Shamji B, del-Rosario A, Dhariwal J, Kirk PDW, Stumpf MPH, Koopmann J, Telcian A, Aniscenko J, Gogsadze L, Bakhsoliani E, Stanciu L, Bartlett N, Edwards M, Walton R, Mallia P, Hunt TM, Hunt TL, Hunt DG, Westwick J, Edwards M, Kon OM, Jackson DJ, Johnston SL (2017) A Comprehensive evaluation of nasal and bronchial cytokines and chemokines following experimental rhinovirus infection in allergic asthma: increased interferons (IFN-gamma and IFN-lambda) and type 2 inflammation (IL-5 and IL-13). EBioMedicine 19:128\u2013138","journal-title":"EBioMedicine"},{"issue":"3","key":"770_CR68","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/thoraxjnl-2012-202909","volume":"69","author":"A Sykes","year":"2014","unstructured":"Sykes A, Macintyre J, Edwards MR, Del Rosario A, Haas J, Gielen V, Kon OM, McHale M, Johnston SL (2014) Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax 69(3):240\u2013246","journal-title":"Thorax"},{"issue":"1","key":"770_CR69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2016.10.049","volume":"140","author":"C Bielor","year":"2017","unstructured":"Bielor C, Sopel N, Maier A, Blau A, Sharma H, Vuorinen T, Kross B, Mittler S, Graser A, Mousset S, Melichar VO, Kiefer A, Zimmermann T, Springel R, Holzinger C, Trump S, Taka S, Papadopoulos NG, Weiss ST, Finotto S (2017) Role of TGF-beta in anti-rhinovirus immune responses in asthmatic patients. J Allergy Clin Immunol 140(1):283\u2013286 e10","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"770_CR70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1074-7613(03)00057-8","volume":"18","author":"T Usui","year":"2003","unstructured":"Usui T, Nishikomori R, Kitani A, Strober W (2003) GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rbeta2 chain or T-bet. Immunity 18(3):415\u2013428","journal-title":"Immunity"},{"issue":"4","key":"770_CR71","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2012.09.007","volume":"37","author":"J Zhu","year":"2012","unstructured":"Zhu J, Jankovic D, Oler AJ, Wei G, Sharma S, Hu G, Guo L, Yagi R, Yamane H, Punkosdy G, Feigenbaum L, Zhao K, Paul WE (2012) The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37(4):660\u2013673","journal-title":"Immunity"},{"issue":"6","key":"770_CR72","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","volume":"100","author":"SJ Szabo","year":"2000","unstructured":"Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100(6):655\u2013669","journal-title":"Cell"},{"issue":"9","key":"770_CR73","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20011956","volume":"195","author":"MF Neurath","year":"2002","unstructured":"Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR, Bhan A, Autschbach F, Sullivan BM, Szabo SJ, Glimcher LH, Blumberg RS (2002) The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn\u2019s disease. J Exp Med 195(9):1129\u20131143","journal-title":"J Exp Med"},{"issue":"5553","key":"770_CR74","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.1065544","volume":"295","author":"S Finotto","year":"2002","unstructured":"Finotto S, Neurath MF, Glickman JN, Qin S, Lehr HA, Green FH, Ackerman K, Haley K, Galle PR, Szabo SJ, Drazen JM, De Sanctis GT, Glimcher LH (2002) Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295(5553):336\u2013338","journal-title":"Science"},{"issue":"5","key":"770_CR75","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1002\/jcp.27422","volume":"234","author":"X Liu","year":"2019","unstructured":"Liu X, Li S, Jin J, Zhu T, Xu K, Liu C, Zeng Y, Mao R, Wang X, Chen Z (2019) Preventative tracheal administration of interleukin-27 attenuates allergic asthma by improving the lung Th1 microenvironment. J Cell Physiol 234(5):6642\u20136653","journal-title":"J Cell Physiol"},{"issue":"11","key":"770_CR76","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/14728222.2016.1206891","volume":"20","author":"M Joerger","year":"2016","unstructured":"Joerger M, Finn SP, Cuffe S, Byrne AT, Gray SG (2016) The IL-17-Th1\/Th17 pathway: an attractive target for lung cancer therapy? Expert Opin Ther Targets 20(11):1339\u20131356","journal-title":"Expert Opin Ther Targets"},{"key":"770_CR77","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ncomms1609","volume":"2","author":"S Reppert","year":"2011","unstructured":"Reppert S, Boross I, Koslowski M, Tureci O, Koch S, Lehr HA, Finotto S (2011) A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer. Nat Commun 2:600","journal-title":"Nat Commun"},{"key":"770_CR78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12950-018-0191-x","volume":"15","author":"L Xu","year":"2018","unstructured":"Xu L, Sun WJ, Jia AJ, Qiu LL, Xiao B, Mu L, Li JM, Zhang XF, Wei Y, Peng C, Zhang DS, Xiang XD (2018) MBD2 regulates differentiation and function of Th17 cells in neutrophils- dominant asthma via HIF-1alpha. J Inflamm 15:15","journal-title":"J Inflamm"},{"key":"770_CR79","unstructured":"Vroman H, Bergen IM, van Hulst JAC, van Nimwegen M, van Uden D, Schuijs MJ, Pillai SY, van Loo G, Hammad H, Lambrecht BN, Hendriks RW, Kool M (2018) TNF-alpha-induced protein 3 levels in lung dendritic cells instruct TH2 or TH17 cell differentiation in eosinophilic or neutrophilic asthma. 141(5):1620\u2013J Allergy Clin Immunol, 1633 e12"},{"issue":"1","key":"770_CR80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/crj.12503","volume":"12","author":"L Wang","year":"2018","unstructured":"Wang L, Wan H, Tang W, Ni Y, Hou X, Pan L, Song Y, Shi G (2018) Critical roles of adenosine A2A receptor in regulating the balance of Treg\/Th17 cells in allergic asthma. Clin Respir J 12(1):149\u2013157","journal-title":"Clin Respir J"},{"key":"770_CR81","doi-asserted-by":"crossref","unstructured":"Guan Q, Yang B, Warrington RJ, Mink S, Kalicinsky C, Becker AB, Simons E, Peng Z (2019) Myeloid-derived suppressor cells: roles and relations with Th2, Th17, and Treg cells in asthma. Allergy","DOI":"10.1111\/all.13829"},{"key":"770_CR82","doi-asserted-by":"crossref","unstructured":"Ramakrishnan RK, Al Heialy S, Hamid Q (2019) Role of IL-17 in asthma pathogenesis and its implications for the clinic. Expert Rev Respir Med:1\u201312","DOI":"10.1080\/17476348.2019.1666002"},{"issue":"2","key":"770_CR83","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/0300060518803828","volume":"47","author":"Z Quan-San","year":"2019","unstructured":"Quan-San Z, Xiaohong X, Ying L, Zhaojia S (2019) Role of Th17-cell related cytokines in geriatric asthma. J Int Med Res 47(2):580\u2013590","journal-title":"J Int Med Res"},{"key":"770_CR84","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2147\/TCRM.S172262","volume":"14","author":"XL Zou","year":"2018","unstructured":"Zou XL, Chen ZG, Zhang TT, Feng DY, Li HT, Yang HL (2018) Th17\/Treg homeostasis, but not Th1\/Th2 homeostasis, is implicated in exacerbation of human bronchial asthma. Ther Clin Risk Manag 14:1627\u20131636","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"770_CR85","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0962-8924(94)90202-X","volume":"4","author":"J Massague","year":"1994","unstructured":"Massague J, Attisano L, Wrana JL (1994) The TGF-beta family and its composite receptors. Trends Cell Biol 4(5):172\u2013178","journal-title":"Trends Cell Biol"},{"issue":"5955","key":"770_CR86","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1172702","volume":"326","author":"A Chaudhry","year":"2009","unstructured":"Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, Rudensky AY (2009) CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326(5955):986\u2013991","journal-title":"Science"},{"issue":"6","key":"770_CR87","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jaci.2018.04.012","volume":"141","author":"A DeVries","year":"2018","unstructured":"DeVries A, Vercelli D (2018) Of pleiotropy and trajectories: Does the TGF-beta pathway link childhood asthma and chronic obstructive pulmonary disease? J Allergy Clin Immunol 141(6):1992\u20131996","journal-title":"J Allergy Clin Immunol"},{"key":"770_CR88","doi-asserted-by":"crossref","unstructured":"Branchett WJ, Stolting H, Oliver RA, Walker SA, Puttur F, Gregory LG, Gabrysova L, Wilson MS, O'Garra A, Lloyd CM (2019) A T cell-myeloid IL-10 axis regulates pathogenic IFN-gamma-dependent immunity in a mouse model of type 2-low asthma. J Allergy Clin Immunol","DOI":"10.1016\/j.jaci.2019.08.006"},{"issue":"3","key":"770_CR89","first-page":"146","volume":"17","author":"E Zonoobi","year":"2018","unstructured":"Zonoobi E, Saeedfar K, Pourdowlat G, Masjedi MR, Behmanesh M (2018) The study of IL-10 and IL-17A genes expression in patients with different stages of asthma: a case-control study. Tanaffos 17(3):146\u2013154","journal-title":"Tanaffos"},{"issue":"9","key":"770_CR90","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3390\/ijms19092571","volume":"19","author":"Milena Paw","year":"2018","unstructured":"Paw M, Wnuk D, Kadziolka D, Sek A, Lasota S, Czyz J, Madeja Z, Michalik M (2018) Fenofibrate reduces the asthma-related fibroblast-to-myofibroblast transition by TGF-beta\/Smad2\/3 signaling attenuation and connexin 43-dependent phenotype destabilization. Int J Mol Sci 19(9)","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"770_CR91","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4168\/aair.2018.10.5.543","volume":"10","author":"S Chen","year":"2018","unstructured":"Chen S, Han Y, Chen H, Wu J, Zhang M (2018) Bcl11b regulates IL-17 through the TGF-beta\/Smad pathway in HDM-induced asthma. Allergy, Asthma Immunol Res 10(5):543\u2013554","journal-title":"Allergy, Asthma Immunol Res"},{"issue":"6","key":"770_CR92","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.jaci.2019.02.007","volume":"143","author":"E Haspeslagh","year":"2019","unstructured":"Haspeslagh E, Vanheerswynghels M, Deswarte K, Van Moorleghem J, Jacquet A, Lambrecht BN, Hammad H (2019) Prophylactic allergen immunotherapy with Der p 2 prevents murine asthma by regulating lung GM-CSF. J Allergy Clin Immunol 143(6):2307\u20132311 e5","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"770_CR93","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.1401612","volume":"194","author":"L Bohm","year":"2015","unstructured":"Bohm L, Maxeiner J, Meyer-Martin H, Reuter S, Finotto S, Klein M, Schild H, Schmitt E, Bopp T, Taube C (2015) IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma. J Immunol 194(3):887\u2013897","journal-title":"J Immunol"},{"key":"770_CR94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13601-017-0160-0","volume":"7","author":"F Asamoah","year":"2017","unstructured":"Asamoah F, Kakourou A, Dhami S, Lau S, Agache I, Muraro A, Roberts G, Akdis C, Bonini M, Cavkaytar O, Flood B, Izuhara K, Jutel M, Kalayci O, Pfaar O, Sheikh A (2017) Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews. Clin Transl Allergy 7:25","journal-title":"Clin Transl Allergy"},{"issue":"12","key":"770_CR95","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","volume":"72","author":"S Dhami","year":"2017","unstructured":"Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, Muraro A, Roberts G, Akdis CA, Bonini M, Cavkaytar O, Flood B, Gajdanowicz P, Izuhara K, Kalayci O, Mosges R, Palomares O, Pfaar O, Smolinska S, Sokolowska M, Asaria M, Netuveli G, Zaman H, Akhlaq A, Sheikh A (2017) Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis. Allergy 72(12):1825\u20131848","journal-title":"Allergy"},{"issue":"5","key":"770_CR96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/1744666X.2019.1574571","volume":"15","author":"KM MacDonald","year":"2019","unstructured":"MacDonald KM, Kavati A, Ortiz B, Alhossan A, Lee CS, Abraham I (2019) Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018. Expert Rev Clin Immunol 15(5):553\u2013569","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"770_CR97","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2019.9.e7","volume":"9","author":"S Nishima","year":"2019","unstructured":"Nishima S, Kozawa M, Milligan KL, Papadopoulos NG (2019) Omalizumab and unmet needs in severe asthma and allergic comorbidities in Japanese children. Asia Pac Allergy 9(1):e7","journal-title":"Asia Pac Allergy"},{"issue":"5","key":"770_CR98","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/all.13678","volume":"74","author":"A Deschildre","year":"2019","unstructured":"Deschildre A, Roussel J, Drumez E, Abou-Taam R, Rames C, Le Roux P, Pouessel G, Scalbert M, Bonnel C, Mitha S, Boileau S, Mordacq C, Thumerelle C, Labreuche J, Lejeune S, Marguet C (2019) Omalizumab discontinuation in children with severe allergic asthma: an observational real-life study. Allergy 74(5):999\u20131003","journal-title":"Allergy"},{"issue":"6","key":"770_CR99","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jaip.2019.01.023","volume":"7","author":"A Fiocchi","year":"2019","unstructured":"Fiocchi A, Artesani MC, Riccardi C, Mennini M, Pecora V, Fierro V, Calandrelli V, Dahdah L, Valluzzi RL (2019) Impact of omalizumab on food allergy in patients treated for asthma: a real-life study. J Allergy Clin Immunol Pract 7(6):1901\u20131909 e5","journal-title":"J Allergy Clin Immunol Pract"},{"key":"770_CR100","first-page":"1","volume":"22","author":"E Weir","year":"2019","unstructured":"Weir E, Paton J (2019) Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center\u2019s early clinical experience. J Asthma 22:1\u20134","journal-title":"J Asthma"},{"issue":"2","key":"770_CR101","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18176\/jiaci.0385","volume":"29","author":"I Davila Gonzalez","year":"2019","unstructured":"Davila Gonzalez I, Moreno Benitez F, Quirce S (2019) Benralizumab: a new approach for the treatment of severe eosinophilic asthma. J Investig Allergol Clin Immunol 29(2):84\u201393","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"5","key":"770_CR102","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.anai.2019.02.016","volume":"122","author":"G Chupp","year":"2019","unstructured":"Chupp G, Lugogo NL, Kline JN, Ferguson GT, Hirsch I, Goldman M, Zangrilli JG, Trudo F (2019) Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma. Ann Allergy Asthma Immunol 122(5):478\u2013485","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"770_CR103","doi-asserted-by":"crossref","first-page":"e00388","DOI":"10.1002\/rcr2.388","volume":"7","author":"D Minami","year":"2019","unstructured":"Minami D, Kayatani H, Sato K, Fujiwara K, Shibayama T (2019) Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab. Respirol Case Rep 7(1):e00388","journal-title":"Respirol Case Rep"},{"issue":"1","key":"770_CR104","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-2600(18)30406-5","volume":"7","author":"WW Busse","year":"2019","unstructured":"Busse WW, Bleecker ER, FitzGerald JM, Ferguson GT, Barker P, Sproule S, Olsson RF, Martin UJ, Goldman M, B.s. investigators (2019) Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial. Lancet Respir Med 7(1):46\u201359","journal-title":"Lancet Respir Med"},{"key":"770_CR105","first-page":"1","volume":"1","author":"Y Zayed","year":"2018","unstructured":"Zayed Y, Kheiri B, Banifadel M, Hicks M, Aburahma A, Hamid K, Bachuwa G, Chandran A (2018) Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials. J Asthma 1:1\u201310","journal-title":"J Asthma"},{"issue":"1","key":"770_CR106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.anai.2018.08.005","volume":"122","author":"J Corren","year":"2019","unstructured":"Corren J, Castro M, Chanez P, Fabbri L, Joish VN, Amin N, Graham NMH, Mastey V, Abbe A, Taniou C, Mahajan P, Teper A, Pirozzi G, Eckert L (2019) Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma. Ann Allergy Asthma Immunol 122(1):41\u201349 e2","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"26","key":"770_CR107","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A (2018) Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med 378(26):2475\u20132485","journal-title":"N Engl J Med"},{"issue":"26","key":"770_CR108","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378(26):2486\u20132496","journal-title":"N Engl J Med"},{"issue":"5","key":"770_CR109","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12325-018-0702-4","volume":"35","author":"WW Busse","year":"2018","unstructured":"Busse WW, Maspero JF, Rabe KF, Papi A, Wenzel SE, Ford LB, Pavord ID, Zhang B, Staudinger H, Pirozzi G, Amin N, Akinlade B, Eckert L, Chao J, Graham NMH, Teper A (2018) Liberty asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate Dupilumab efficacy\/safety in patients with uncontrolled, moderate-to-severe asthma. Adv Ther 35(5):737\u2013748","journal-title":"Adv Ther"},{"issue":"1","key":"770_CR110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.11.051","volume":"142","author":"SF Weinstein","year":"2018","unstructured":"Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, Joish VN, Amin N, Maroni J, Rowe P, Graham NMH, Teper A (2018) Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol 142(1):171\u2013177 e1","journal-title":"J Allergy Clin Immunol"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-019-00770-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-019-00770-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-019-00770-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:30:48Z","timestamp":1695407448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-019-00770-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1007\/s00281-019-00770-3","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}